In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

It took GLP-1 medications like Ozempic just seven years to surpass insulin as the the second most common treatment for type 2 ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Real-world studies on GLP-1s like Ozempic show lower weight loss than clinical trials, with high discontinuation rates due to ...

Viking Therapeutics (VKTX) leads the race to win FDA Rx-to-OTC switch for an oral weight loss drug belonging to GLP-1 class ...

While this class of drugs becomes ever more prevalent, and the wide-ranging positive health outcomes become better known, ...

Recent research easing suicidality concerns about GLP-1s and suggesting potential psychiatric benefit has led to a call for ...

Hims & Hers' (HIMS) stock drop marks the latest overhang on a company that has more than doubled in value over the past 12 ...

GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...

A personalized approach is especially important when it comes to GLP-1s and considerations such as step therapy, side effect management, and medication adherence to ensure everyone receives the ...